SCOTT HIRSCH: Open Payments
NPI 1851514434 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,628 in 194 payments from 20 companies in 2025. Trend: 2023 $10,884 · 2024 $9,992 · 2025 $30,628
Honoraria: $16,775Speaker / faculty: $9,000Food & beverage: $4,312Travel & lodging: $328Education: $213
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 24 | $17,853 |
| ABBVIE INC. | 35 | $9,778 |
| Teva Pharmaceuticals USA, Inc. | 22 | $723 |
| Alkermes, Inc. | 19 | $361 |
| Vanda Pharmaceuticals Inc. | 6 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $314 |
| E.R. Squibb & Sons, L.L.C. | 19 | $308 |
| Neurocrine BioSciences, Inc. | 25 | $298 |
| Otsuka America Pharmaceutical, Inc. | 12 | $195 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $92 |
Products named: Auvelity, VRAYLAR, AUSTEDO XR, CAPLYTA, COBENFY, INGREZZA, ARISTADA, FANAPT.
Industry payments across NY — which companies pay providers there.
